P. Dávila‐Seijo

Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry

P. Dávila‐Seijo, E. Daudén, M.Á. Descalzo et al. · Journal of Investigative Dermatology · 2016 · 125 citations · Full text

Medicine, Dermatology, Pharmacotherapy +9

Survival of classic and biological systemic drugs in psoriasis: results of the <scp>BIOBADADERM</scp> registry and critical analysis

P. Dávila‐Seijo, E. Daudén, G. Carretero et al. · Journal of the European Academy of Dermatology and Venereology · 2016 · 98 citations

Pharmacy, Dermatology, Pharmacotherapy +17

Prioritization of therapy uncertainties in Dystrophic Epidermolysis Bullosa: where should research direct to? an example of priority setting partnership in very rare disorders

P. Dávila‐Seijo, Á. Hernández‐Martín, E. Morcillo-Makow et al. · Orphanet Journal of Rare Diseases · 2013 · 41 citations · Full text

Medicine, Clinical Sciences, Dermatology +14

Drug Survival Analysis Is Not a Good Method for Assessing the Safety or Effectiveness of Systemic Therapies in Psoriasis

P. Dávila‐Seijo, I. García‐Doval · Actas Dermo-Sifiliográficas · 2016 · 22 citations · Full text

Medicine, Dermatology, Pharmacotherapy +7

Topical N‐Acetylcysteine for the Treatment of Lamellar Ichthyosis: An Improved Formula

P. Dávila‐Seijo, Ángeles Flórez, Carmela Dávila-Pousa et al. · Pediatric Dermatology · 2014 · 16 citations · Full text

Pharmacy, Dermatology, Medicinal Chemistry +12